API CAS 58-32-2 Dipyridamole Tablet Raw Material Dipyridamole Powder Pharmaceutical Dipyridamole

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Model NO.: Dsung-Dipyridamole
• Product Name: Dipyridamole
• Name: Dipyridamole Powder
• Appearance: Yellow Powder
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Pharmaceutical Intermediate
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 58-32-2
• Mf: C24h40n8o4
• MW: 504.6256
• Melting Point: 165-166 C
• Boiling Point: 806.5 C at 760 Mmhg
• Density: 1.352
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-Sung
• Origin: Shaanxi
• Production Capacity: 5t/Month

Product Description

API CAS 58-32-2 Dipyridamole Tablet Raw Material Dipyridamole Powder Pharmaceutical Dipyridamole

 

Product Description

Product Details

Product Name	Dipyridamole
CAS No.	58-32-2
MF	C24H40N8O4
MW	504.6256
Appearance and shape	Yellow Powder

Dipyridamole, may be used for coronary andmyocardial insufficiency. Its biggest use today, however, isas an antithrombotic in patients with prosthetic heart valves.It is a bitter, yellow, crystalline powder, soluble in diluteacids, metanol, or chlorofm. A formulation containingdipyridamole and aspirin (Aggrenox) is currently beingmarketed as an antithromobotic.
Dipyridamole is a long-acting vasodilator. Its vasodilatingaction is selective for the coronary system; it is indicatedfor long-term therapy of chronic angina pectoris. Thedrug also inhibits adenosine deaminase in erythrocytesand interferes with the uptake of the vasodilator adenosineby erythrocytes. These actions potentiate the effect ofprostacyclin (PGI2), which acts as an inhibitor to plateletaggregation.

Application & Function

Dipyridamole, a coronary artery dilator and antithrombotic drug, is used mainly for ischemic heart disease and stroke, but to a lesser extent for other conditions.Its side effects may include headache, dizziness, nausea, vomiting, diarrhea and other adverse reactions. Combined with heparin, it may cause bleeding tendency, occasional rash, and coronary artery blood theft.Early years used to be the treatment of coronary heart disease drugs, now less used as an anti-myocardial ischemia.Its anti-platelet aggregation effect can be used in cardiac surgery or valve replacement, which can reduce the formation of thromboembolism.
Dipyridamole is a long-acting vasodilator. Its vasodilatingaction is selective for the coronary system; it is indicatedfor long-term therapy of chronic angina pectoris. Thedrug also inhibits adenosine deaminase in erythrocytesand interferes with the uptake of the vasodilator adenosineby erythrocytes. These actions potentiate the effect ofprostacyclin (PGI2), which acts as an inhibitor to plateletaggregation.

Specification